I'm a bit late in getting this out, due to that pesky job of mine, and that distracting family...
So good news and bad news, but mostly good, I think. The caveat, first though: I was on a placebo-controlled trial (1/3 placebo, 1/3 lower-dose rebamipide, 1/3 higher-dose rebamipide) and I do not know for sure what I received--could have been placebo.
Objectively, the treatment I received (for two months) increased my tear break-up time (TBUT) substantially, to nearly ten seconds on last exam (Thursday, June 2), from my normal baseline 2-3 secs. This is a big-time improvement--I don't think I've ever measured above 5 since surgery.
Also, the treatment very noticeably improved my corneal staining on fluorescein and lissamine green test. (Anyone had the lissamine green before? It stains not just your eyes/lids, but also the area around your eyes, so you end up with an Alice Cooper sort of look afterwards. But I digress...) Both tests had me with 4 areas in each eye with scores of 2 prior to treatment and only one 2-score in left eye after 2 months rebamipide. Again, substantial improvement, from 8 2-scores (higher is worse) to 1 after 2 months.
Schirmer was up a bit in right eye only: about 4 mm. Still <1 mm in left eye, which has always been the more symptomatic one.
Now the bad news: I did not feel a ton better on the rebamipide. Actually, I didn't feel any better, to be completely honest. However, I only got the drug (vs placebo) for 2 months, and most people required around 4 months to notice subjective benefit, according to the doctor and nurse with whom I spoke (and trust me--I hit them up for any info I could get out of them).
Which leads to the really bad news (for me at least, but only temporarily): I am being moved by the Army and was not given the option of "taking the study with me," so I am off trial now, and will not be able to give you any more news, good or bad, until the drug gets FDA-approved.
Bottom line, though: I had some objectively verifiable improvements in TBUT and corneal staining on this study, and the doctors and nurse i spoke with said that "lots" of patients are having objective and subjective benefits. There are about four similar drugs (mucin-enhancers) undergoing clinical trials right now, so one of these will probably be ready for primetime next year (I hope?).
Other info: my treatment was 4 drops in each eye every day, milky-white fluid, kind of like Soothe eyedrops. They did not burn, except for an occasional brief sting right on instillation (which I sometimes get with Dwelle/Dakrina as well). Generally was a comfortable drop. Worst side effect was a very bad taste in my mouth, which would not be an issue with eople who are 4x plugged/cauterized. I got used to it, but it was bothersome at first.
Again, sorry to keep you waiting on this, but Hopefully it was worth waiting for. A promising drug, I think. (I HOPE.)
So good news and bad news, but mostly good, I think. The caveat, first though: I was on a placebo-controlled trial (1/3 placebo, 1/3 lower-dose rebamipide, 1/3 higher-dose rebamipide) and I do not know for sure what I received--could have been placebo.
Objectively, the treatment I received (for two months) increased my tear break-up time (TBUT) substantially, to nearly ten seconds on last exam (Thursday, June 2), from my normal baseline 2-3 secs. This is a big-time improvement--I don't think I've ever measured above 5 since surgery.
Also, the treatment very noticeably improved my corneal staining on fluorescein and lissamine green test. (Anyone had the lissamine green before? It stains not just your eyes/lids, but also the area around your eyes, so you end up with an Alice Cooper sort of look afterwards. But I digress...) Both tests had me with 4 areas in each eye with scores of 2 prior to treatment and only one 2-score in left eye after 2 months rebamipide. Again, substantial improvement, from 8 2-scores (higher is worse) to 1 after 2 months.
Schirmer was up a bit in right eye only: about 4 mm. Still <1 mm in left eye, which has always been the more symptomatic one.
Now the bad news: I did not feel a ton better on the rebamipide. Actually, I didn't feel any better, to be completely honest. However, I only got the drug (vs placebo) for 2 months, and most people required around 4 months to notice subjective benefit, according to the doctor and nurse with whom I spoke (and trust me--I hit them up for any info I could get out of them).
Which leads to the really bad news (for me at least, but only temporarily): I am being moved by the Army and was not given the option of "taking the study with me," so I am off trial now, and will not be able to give you any more news, good or bad, until the drug gets FDA-approved.
Bottom line, though: I had some objectively verifiable improvements in TBUT and corneal staining on this study, and the doctors and nurse i spoke with said that "lots" of patients are having objective and subjective benefits. There are about four similar drugs (mucin-enhancers) undergoing clinical trials right now, so one of these will probably be ready for primetime next year (I hope?).
Other info: my treatment was 4 drops in each eye every day, milky-white fluid, kind of like Soothe eyedrops. They did not burn, except for an occasional brief sting right on instillation (which I sometimes get with Dwelle/Dakrina as well). Generally was a comfortable drop. Worst side effect was a very bad taste in my mouth, which would not be an issue with eople who are 4x plugged/cauterized. I got used to it, but it was bothersome at first.
Again, sorry to keep you waiting on this, but Hopefully it was worth waiting for. A promising drug, I think. (I HOPE.)
Comment